Skip to content


Lyphe are a private and independent group. We have built all of our businesses from the ground up, and boast the largest market share in the U.K. today. For information on investing in Lyphe, please get in touch.

Our pursuit is for patient access to be mainstream and global.

+130k Cannabis units despatched
+9k Patient consultations
35% UK market share
3x Digital platforms
No.1 Own label cannabis brand
600 Healthcare professionals trained

Investor Enquiries